Marshall Wace
INMB icon

Marshall Wace’s INmune Bio INMB Stock Holding History

Marshall Wace’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-58,087
Closed -$454K – 2918
2025
Q1 		$454K Sell
58,087
-19,381
-25% -$154K ﹤0.01% 2117
2024
Q4 		$362K Sell
77,468
-2,420
-3% -$12.6K ﹤0.01% 2172
2024
Q3 		$431K Sell
79,888
-36,028
-31% -$256K ﹤0.01% 1971
2024
Q2 		$1.02M Buy
115,916
+89,091
+332% +$878K ﹤0.01% 1680
2024
Q1 		$315K Buy
+26,825
New +$324K ﹤0.01% 2093
2022
Q2 		– Sell
-67,373
Closed -$568K – 3633
2022
Q1 		$568K Buy
67,373
+9,991
+17% +$89.7K ﹤0.01% 2719
2021
Q4 		$585K Sell
57,382
-7,268
-11% -$108K ﹤0.01% 2724
2021
Q3 		$1.26M Buy
+64,650
New +$1.25M 0.01% 1871

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Marshall Wace's INMB Position: Q2 2025 in Review

Marshall Wace sold out of INmune Bio (INMB) in Q2 2025, closing a stake of 58,087 shares — an estimated $454K sold.

Marshall Wace first reported a position in INMB in Q3 2021 and held it in 8 quarters. The position peaked at $1.26M in Q3 2021. 79 funds tracked by Wall St. Rank hold INMB as of Q2 2025.

  • Marshall Wace reported no remaining INmune Bio position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 58,087 INmune Bio shares in Q2 2025, an estimated $454K.
  • Marshall Wace first reported a position in INmune Bio in Q3 2021 and held it in 8 quarters.
  • Marshall Wace's INmune Bio position peaked at $1.26M in Q3 2021.
  • 79 funds tracked by Wall St. Rank held INmune Bio as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.